A detailed history of Pvg Asset Management Corp transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Pvg Asset Management Corp holds 78,490 shares of AVXL stock, worth $633,414. This represents 4.75% of its overall portfolio holdings.

Number of Shares
78,490
Previous 13,005 503.54%
Holding current value
$633,414
Previous $73,000 1053.42%
% of portfolio
4.75%
Previous 0.32%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 21, 2025

BUY
$5.11 - $12.56 $334,628 - $822,491
65,485 Added 503.54%
78,490 $842,000
Q3 2024

Nov 25, 2024

BUY
$4.11 - $7.04 $53,450 - $91,555
13,005 New
13,005 $73,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $629M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Pvg Asset Management Corp Portfolio

Follow Pvg Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pvg Asset Management Corp with notifications on news.